Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma
Autolus Limited
Autolus Limited
CRISPR Therapeutics
Pfizer
Emergent BioSolutions
miRagen Therapeutics, Inc.
Spectrum Pharmaceuticals, Inc
miRagen Therapeutics, Inc.
Agios Pharmaceuticals, Inc.
Celgene
Mundipharma Research Limited